Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goda Choi

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Bone Marrow Transplantation|February 24, 2023
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Bone Marrow Transplantation|June 20, 2021
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCTWalter J F M van der Velden, Goda Choi, Moniek A de Witte, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Transplantation and Cellular Therapy|March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional ChemotherapyJacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Intensive Care Medicine Experimental|July 29, 2015
The receptor for advanced glycation end products in ventilator-induced lung injuryMaria T Kuipers, Hamid Aslami, Pieter Roel Tuinman, et al.
Cancer Medicine|November 26, 2020
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)Francesco Saraceni, Myriam Labopin, Edouard Forcade, et al.
Bone Marrow Transplantation|October 18, 2025
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMTArnon Nagler, Jacques-Emmanuel Galimard, Sarah Kayser, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Bone Marrow Transplantation|February 24, 2023
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Bone Marrow Transplantation|June 20, 2021
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCTWalter J F M van der Velden, Goda Choi, Moniek A de Witte, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Transplantation and Cellular Therapy|March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional ChemotherapyJacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Intensive Care Medicine Experimental|July 29, 2015
The receptor for advanced glycation end products in ventilator-induced lung injuryMaria T Kuipers, Hamid Aslami, Pieter Roel Tuinman, et al.
Cancer Medicine|November 26, 2020
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)Francesco Saraceni, Myriam Labopin, Edouard Forcade, et al.
Bone Marrow Transplantation|October 18, 2025
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMTArnon Nagler, Jacques-Emmanuel Galimard, Sarah Kayser, et al.
Bone Marrow Transplantation|June 29, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Pageof 7